Meeting ReportOncology: Clinical Therapy & Diagnosis (includes Phase 2, Phase 3, post approval studies) - GU
Inter- and intra-reader reproducibility of 18F-rhPSMA-7.3 PET interpretation in patients with newly diagnosed prostate cancer: Results from a phase 3, prospective, multicenter study (LIGHTHOUSE)
Phillip Kuo, Gregory Ravizzini, Gary Ulaner, Don Yoo and Katherine Zukotynski
Journal of Nuclear Medicine June 2023, 64 (supplement 1) P589;
Phillip Kuo
1University of Arizona College of Medicine-Tucson
Gregory Ravizzini
2MD Anderson Cancer Center
Gary Ulaner
3Hoag Family Cancer Institute
Don Yoo
4Warren Alpert Medical School of Brown University, Providence, RI, USA
Katherine Zukotynski
5Department of Radiology, McMaster University

Article Figures & Data
In this issue
Journal of Nuclear Medicine
Vol. 64, Issue supplement 1
June 1, 2023
Inter- and intra-reader reproducibility of 18F-rhPSMA-7.3 PET interpretation in patients with newly diagnosed prostate cancer: Results from a phase 3, prospective, multicenter study (LIGHTHOUSE)
Phillip Kuo, Gregory Ravizzini, Gary Ulaner, Don Yoo, Katherine Zukotynski
Journal of Nuclear Medicine Jun 2023, 64 (supplement 1) P589;
Inter- and intra-reader reproducibility of 18F-rhPSMA-7.3 PET interpretation in patients with newly diagnosed prostate cancer: Results from a phase 3, prospective, multicenter study (LIGHTHOUSE)
Phillip Kuo, Gregory Ravizzini, Gary Ulaner, Don Yoo, Katherine Zukotynski
Journal of Nuclear Medicine Jun 2023, 64 (supplement 1) P589;
Jump to section
Related Articles
- No related articles found.
Cited By...
- No citing articles found.